Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02384239
Title A Study of Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, San Francisco

breast cancer

Her2-receptor negative breast cancer


Fulvestrant + Palbociclib

Palbociclib + Tamoxifen

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.